Posted by Michael Wonder on 06 Feb 2023
Pharma industry urges halt to further rises in record revenue clawbacks
2 February 2023 - The pharmaceutical industry is calling on the government to scrap plans to raise the statutory revenue clawback rate from 24.4% to a record 27.5%.
Doing so is a fundamental first step to reassuring investors about the UK’s ambition to halt the contraction of UK life sciences, and to secure a positive outcome to critical upcoming negotiations with the industry.
